What is the approximate market price of a box of lorlatinib/lorlatinib?

Lorlatinib/Lorlatinib ( Lorlatinib), as a relatively new targeted therapy drug, has been marketed in many countries and is mainly used to treat patients with ALK mutation-positive non-small cell lung cancer. The global market price of this drug varies depending on region, brand, drug strength, and market policies. Understanding this information is especially important for patients and their families when choosing treatment options.

In China, lorlatinib tablets (the Chinese trade name of lorlatinib) have been included in the scope of medical insurance reimbursement. According to the common specifications in the instructions, the packaging specifications of lorlatinib are usually 25mg*90 tablets and 100mg*30 tablets. Among them, the price of 25mg medicines per box is about 20,000 yuan, and the price of 100mg medicines is also about 20,000 yuan. Since the drug has been covered by medical insurance in China, some patients can be reimbursed through medical insurance if they meet the medical insurance conditions, and the actual cost paid will be reduced.

Compared with the domestic market price, the market price of original drugs in Hong Kong is usually higher, usually RMB 30,000 to RMB 50,000. This is mainly due to the higher price of imported drugs in the Hong Kong market and the imbalance between the demand and supply of drugs. The price of original drugs produced in Turkey is relatively close to the people, usually around 10,000 yuan. The price difference is mainly due to factors such as production costs, market demand, taxes and fees of drugs in various countries.

In addition to original drugs, there are also some generic drugs on the market. The ingredients of these generic drugs are basically the same as the original drugs, but due to lower production costs, the prices are usually much cheaper. For example, a generic drug of 100mg*30 tablets produced by a pharmaceutical factory in Laos sells for about 1,000 yuan. The price difference of this generic drug is mainly due to the lower procurement cost of raw materials in the place of production and the reduction of intermediate costs.

References：https://www.lorbrena.com/